Braden Michael Leonard, 10% Owner at AN2 Therapeutics, Inc. (ANTX), sold 400,000 shares at $1.09 ($436K) on 2025-05-28, disclosed to the SEC on 2025-06-16.
Open-market sale of $436k ANTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.09 | 200,000 | $218K | 50.0% |
| 2 | $1.09 | 200,000 | $218K | 50.0% |
| Total | $1.09 avg | 400,000 | $436K | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-05-30 | $3.0M | — | Filing → |